University of Texas M D Anderson Cancer Center — Houston, Texas

University of Texas M D Anderson Cancer Center is a clinical research site located in Houston, Texas, United States 77030.

Crixeo Clinical Trials Trust Score: 93/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Texas M D Anderson Cancer Center has participated in 97 clinical trials with 18 currently active.

Therapeutic areas: Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia (ALL), Sarcoma.

Sponsors: Hybrigenics Corporation, Spectrum Pharmaceuticals, Inc, Hoffmann-La Roche.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Houston

Browse all research sites in Texas · View every site in Houston

Sponsor Feasibility Report

Trust Score: 93/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Texas M D Anderson Cancer Center?

University of Texas M D Anderson Cancer Center has a Crixeo Trust Score of 93/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Texas M D Anderson Cancer Center conducted?

University of Texas M D Anderson Cancer Center has 97 clinical trials on record, with 18 currently active. Their work covers Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia (ALL), Sarcoma.

Is University of Texas M D Anderson Cancer Center accredited by Crixeo Clinical Trials?

University of Texas M D Anderson Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Texas M D Anderson Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.